Edit |   |
---|---|
Antigenic Specificity | CD94, Human (Monalizumab biosimilar) |
Clone | Monalizumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG4 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | ELISA, IHC, IF, IP, FCM, FuncS |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD94 Recombinant Antibody. Monalizumab (formerly IPH2201) is an investigational drug being studied for rheumatoid arthritis, gynecologic malignancies and other cancers. |
Immunogen | n/a |
Other Names | Anti-CD94 Recombinant Antibody, Research Grade Monalizumab, Anti-Human CD94 Recombinant Antibody, IPH-2201, NN-8765, NNC-0141-0000-0100, Antibody Drug Analogues, Monoclonal Antibody, YR1381, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1228763-95-8 |
Catalog # | YR1381 |
Price | please inquire |
Order / More Info | CD94, Human (Monalizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |